{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:44:19Z","timestamp":1778755459563,"version":"3.51.4"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01925","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T04:19:14Z","timestamp":1534997954000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections"],"prefix":"10.3389","volume":"9","author":[{"given":"Jeroen D.","family":"Langereis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00366.x","article-title":"The plasticity of immunoglobulin gene systems in evolution","volume":"210","author":"Hsu","year":"2006","journal-title":"Immunol Rev."},{"key":"B2","volume-title":"Stiehm's Immune Deficiencies","author":"Sullivan","year":"2014"},{"key":"B3","article-title":"Immunobiology: the immune system in health and disease","author":"Janeway","year":"2005"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B5","first-page":"634","article-title":"The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin","volume":"112","author":"Mankarious","year":"1988","journal-title":"J Lab Clin Med"},{"key":"B6","first-page":"1","article-title":"Metabolism of immunoglobulins","volume":"13","author":"Waldmann","year":"1969","journal-title":"Prog Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1172\/JCI104987","article-title":"Metabolism of human gamma macroglobulins","volume":"43","author":"Barth","year":"1964","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1084\/jem.168.1.127","article-title":"Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q","volume":"168","author":"Bindon","year":"1988","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.178.2.661","article-title":"Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation","volume":"178","author":"Tao","year":"1993","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"Diebolder","year":"2014","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/eji.1830190121","article-title":"Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation","volume":"19","author":"Pluschke","year":"1989","journal-title":"Eur J Immunol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/infdis\/163.2.346","article-title":"Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1","volume":"163","author":"Raff","year":"1991","journal-title":"J Infect Dis."},{"key":"B13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/art.1780250208","article-title":"Activation of the classical pathway of complement by rheumatoid factors","volume":"25","author":"Sabharwal","year":"1982","journal-title":"Arthritis Rheum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/eji.1830180705","article-title":"On the structure of polymeric IgM","volume":"18","author":"Davis","year":"1988","journal-title":"Eur J Immunol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1073\/pnas.69.12.3673","article-title":"Todel: partial duplication in the \u201chinge\u201d region of IgA 1 myeloma proteins","volume":"69","author":"Frangione","year":"1972","journal-title":"Proc Natl Acad Sci USA."},{"key":"B16","first-page":"383","article-title":"IgA subclasses in various secretions and in serum","volume":"47","author":"Delacroix","year":"1982","journal-title":"Immunology"},{"key":"B17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1172\/JCI110777","article-title":"Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A","volume":"71","author":"Delacroix","year":"1983","journal-title":"J Clin Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.0105-2896.2005.00290.x","article-title":"Mucosal immunoglobulins","volume":"206","author":"Woof","year":"2005","journal-title":"Immunol Rev."},{"key":"B19","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1128\/IAI.63.8.3166-3173.1995","article-title":"Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease","volume":"63","author":"Johnson","year":"1995","journal-title":"Infect Immun."},{"key":"B20","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1084\/jem.147.6.1832","article-title":"Secretory component of epithelial cells is a surface receptor for polymeric immunoglobulins","volume":"147","author":"Crago","year":"1978","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/311071a0","article-title":"Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins","volume":"311","author":"Brandtzaeg","year":"1984","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.77.12.7257","article-title":"Receptor-mediated transcellular transport of immunoglobulin: synthesis of secretory component as multiple and larger transmembrane forms","volume":"77","author":"Mostov","year":"1980","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1016\/S0021-9258(18)33837-7","article-title":"A transmembrane precursor of secretory component","volume":"257","author":"Mostov","year":"1982","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4049\/jimmunol.112.3.949","article-title":"Studies on the structural and conformational basis for the relative resistance of serum and secretory immunoglobulin A to proteolysis","volume":"112","author":"Underdown","year":"1974","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/sji.12508","article-title":"Human secretory IgM antibodies activate human complement and offer protection at mucosal surface","volume":"85","author":"Michaelsen","year":"2017","journal-title":"Scand J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/eji.1830150718","article-title":"Isolation and characterization of an Fc receptor from neonatal rat small intestine","volume":"15","author":"Simister","year":"1985","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1172\/JCI6968","article-title":"Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line","volume":"104","author":"Dickinson","year":"1999","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/eji.1830260327","article-title":"Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice","volume":"26","author":"Ghetie","year":"1996","journal-title":"Eur J Immunol"},{"key":"B29","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1073\/pnas.93.11.5512","article-title":"The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor","volume":"93","author":"Junghans","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3201\/eid0402.980210","article-title":"Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease","volume":"4","author":"Bisgard","year":"1998","journal-title":"Emerg Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10875-017-0474-7","article-title":"IgM augments complement bactericidal activity with serum from a patient with a novel CD79a mutation","volume":"38","author":"Langereis","year":"2018","journal-title":"J Clin Immunol"},{"key":"B32","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0140-6736(92)92117-X","article-title":"Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines","volume":"340","author":"Peltola","year":"1992","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0022-3476(97)70035-0","article-title":"Effect of nationwide vaccination of 3-month-old infants in the Netherlands with conjugate Haemophilus influenzae type b vaccine: high efficacy and lack of herd immunity","volume":"131","author":"van Alphen","year":"1997","journal-title":"J Pediatr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clinthera.2011.11.027","article-title":"Two decades of experience with the haemophilus influenzae serotype b conjugate vaccine in the United Kingdom","volume":"34","author":"Ladhani","year":"2012","journal-title":"Clin Ther"},{"key":"B35","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0264-410X(93)90124-G","article-title":"Characterization of the serum antibody response induced by Haemophilus influenzae type b tetanus protein-conjugate vaccine in infants receiving a DTP-combined vaccine from 2 months of age","volume":"11","author":"Barra","year":"1993","journal-title":"Vaccine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1542\/peds.2009-1405","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine","volume":"125","author":"Bryant","year":"2010","journal-title":"Pediatrics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"S536","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"6","author":"Black","year":"2000","journal-title":"Am J Manag Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/Nejm200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"New Eng J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00006454-200203000-00003","article-title":"Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"42137","DOI":"10.1038\/srep42137","article-title":"A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood","volume":"7","author":"van der Maten","year":"2017","journal-title":"Sci Rep"},{"key":"B41","unstructured":"Registry-Diagnosis criteria"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/1744666X.2016.1198696","article-title":"Monogenic mutations associated with IgA deficiency","volume":"12","author":"Abolhassani","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s10875-008-9229-9","article-title":"IgA deficiency: correlation between clinical and immunological phenotypes","volume":"29","author":"Aghamohammadi","year":"2009","journal-title":"J Clin Immunol"},{"key":"B44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00441577","article-title":"Selective IgA deficiency: clinical and immunological evaluation of 50 pediatric patients","volume":"133","author":"Burgio","year":"1980","journal-title":"Eur J Pediatr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10875-012-9702-3","article-title":"Selective IgA deficiency: clinical and laboratory features of 118 children in Turkey","volume":"32","author":"Aytekin","year":"2012","journal-title":"J Clin Immunol"},{"key":"B46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00918659","article-title":"Immunoglobulin levels in saliva in individuals with selective IgA deficiency: compensatory IgM secretion and its correlation with HLA and susceptibility to infections","volume":"9","author":"Norhagen","year":"1989","journal-title":"J Clin Immunol"},{"key":"B47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF00917328","article-title":"Secretory antibodies in IgA-deficient and immunosuppressed individuals","volume":"6","author":"Mellander","year":"1986","journal-title":"J Clin Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the primary immunodeficiency committee of the american academy of allergy, asthma and immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10875-017-0420-8","article-title":"Selective IgM deficiency: clinical and laboratory features of 17 patients and a review of the literature","volume":"37","author":"Chovancova","year":"2017","journal-title":"J Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/cei.13065","article-title":"Truly selective primary IgM deficiency is probably very rare","volume":"191","author":"Janssen","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3389\/fimmu.2017.01056","article-title":"Selective IgM deficiency-an underestimated primary immunodeficiency","volume":"8","author":"Gupta","year":"2017","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: one diagnosis to rule them all?","volume":"53","author":"Bogaert","year":"2016","journal-title":"J Med Genet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1399-3038.2009.00963.x","article-title":"Detection of pulmonary complications in common variable immunodeficiency","volume":"21","author":"Touw","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1067\/mai.2002.124999","article-title":"Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency","volume":"109","author":"Busse","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"B56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0090-1229(82)90022-8","article-title":"Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial","volume":"22","author":"Ammann","year":"1982","journal-title":"Clin Immunol Immunopathol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/clim.2002.5241","article-title":"Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study","volume":"104","author":"Plebani","year":"2002","journal-title":"Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10875-008-9227-y","article-title":"Clinical and molecular analysis of 49 patients with X-linked agammaglobulinemia from a single center in Argentina","volume":"29","author":"Basile","year":"2009","journal-title":"J Clin Immunol."},{"key":"B60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","article-title":"X-linked agammaglobulinemia: an analysis of 96 patients","volume":"64","author":"Lederman","year":"1985","journal-title":"Medicine"},{"key":"B61","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ja01207a034","article-title":"Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids","volume":"68","author":"Cohn","year":"1946","journal-title":"J Am Chem Soc"},{"key":"B62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1021\/ja01170a048","article-title":"The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta1-lipoprotein into subfractions of human plasma","volume":"71","author":"Oncley","year":"1949","journal-title":"J Am Chem Soc"},{"key":"B63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2017.07.008","article-title":"X-Linked Agammaglobulinaemia: outcomes in the modern era","volume":"183","author":"Shillitoe","year":"2017","journal-title":"Clin Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti","year":"2011","journal-title":"J Clin Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10875-017-0381-y","article-title":"Low IgA and IgM Is associated with a higher prevalence of bronchiectasis in primary antibody deficiency","volume":"37","author":"Hodkinson","year":"2017","journal-title":"J Clin Immunol"},{"key":"B67","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"B68","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-3476(62)80092-4","article-title":"A decade with agammaglobulinemia","volume":"60","author":"Bruton","year":"1962","journal-title":"J Pediatr"},{"key":"B69","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(72)90926-9","article-title":"Uptake of IgG after intramuscular and subcutaneous injection","volume":"1","author":"Smith","year":"1972","journal-title":"Lancet"},{"key":"B70","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(86)92826-6","article-title":"Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases","volume":"1","author":"Ochs","year":"1986","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0140-6736(91)90147-H","article-title":"Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion","volume":"338","author":"Gardulf","year":"1991","journal-title":"Lancet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2217\/imt-2016-0066","article-title":"Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability","volume":"8","author":"Wasserman","year":"2016","journal-title":"Immunotherapy"},{"key":"B73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1423-0410.1962.tb03240.x","article-title":"Intravenous administration of human gamma-globulin","volume":"7","author":"Barandun","year":"1962","journal-title":"Vox Sang."},{"key":"B74","first-page":"1","article-title":"Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia","volume":"76","author":"Garbett","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"B75","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1423-0410.1975.tb02791.x","article-title":"Undegraded human immunoglobulin for intravenous use","volume":"28","author":"Stephan","year":"1975","journal-title":"Vox Sang."},{"key":"B76","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1365-2249.2003.02199.x","article-title":"Immunology Nurses","volume":"133","author":"Brennan","year":"2003"},{"key":"B77","first-page":"237","article-title":"Intravenous immunoglobulin therapy for antibody deficiency","volume":"36","author":"Nolte","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"B78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archinte.1967.00290190108008","article-title":"Intravenous administration of modified gamma globulin","volume":"119","author":"Jager","year":"1967","journal-title":"Arch Intern Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10875-006-9002-x","article-title":"Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies\u2013a prospective, multi-national study","volume":"26","author":"Gardulf","year":"2006","journal-title":"J Clin Immunol"},{"key":"B80","first-page":"343","article-title":"Plasma therapy: an alternative to gamma globulin injections in immunodeficiency","volume":"11","author":"Stiehm","year":"1975","journal-title":"Birth Defects Orig Artic Ser"},{"key":"B81","first-page":"376","article-title":"Plasma therapy in immunodeficiency diseases","volume":"124","author":"Buckley","year":"1972","journal-title":"Am J Dis Child."},{"key":"B82","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/BF01960888","article-title":"Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia","volume":"11","author":"Kerstens","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B83","first-page":"933","article-title":"Properties and efficacy of a human immunoglobulin M preparation for intravenous administration","volume":"35","author":"Stephan","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"B84","first-page":"282","article-title":"[Elimination of complement fixation of gamma-globulin by chemical modification with beta-propiolactone]","volume":"7","author":"Stephan","year":"1969","journal-title":"Z Klin Chem Klin Biochem"},{"key":"B85","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1423-0410.1986.tb00203.x","article-title":"Effect of various treatments of gamma-globulin (Igg) for achieving intravenous tolerance on the capacity to interact with human monocyte Fc-receptors - a comparative-study","volume":"51","author":"Jungi","year":"1986","journal-title":"Vox Sang."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e0160907","DOI":"10.1371\/journal.pone.0160907","article-title":"IgM-enriched immunoglobulin attenuates systemic endotoxin activity in early severe sepsis: a before-after cohort study","volume":"11","author":"Wand","year":"2016","journal-title":"PLoS ONE"},{"key":"B87","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.36.10.2139","article-title":"Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins","volume":"36","author":"Behre","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"B88","first-page":"8","article-title":"Opsonic activity of a new intravenous immunoglobulin preparation: pentaglobin compared with sandoglobulin","volume":"76","author":"Garbett","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s15010-014-0706-1","article-title":"In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens","volume":"43","author":"Rossmann","year":"2015","journal-title":"Infection"},{"key":"B90","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/BF02098467","article-title":"Use of an immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with persistent Campylobacter jejuni infection","volume":"12","author":"Borleffs","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B91","article-title":"Treatment of severe community acquired pneumonia","volume-title":"BIOTEST AG","author":"Langohr","year":"2017"},{"key":"B92","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/aas.12652","article-title":"IgM-enriched solution BT086 improves host defense capacity and energy store preservation in a rabbit model of endotoxemia","volume":"60","author":"Shmygalev","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"B93","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","article-title":"Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)","volume":"44","author":"Welte","year":"2018","journal-title":"Intensive Care Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198807073190101","article-title":"Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding","volume":"319","author":"Eibl","year":"1988","journal-title":"N Engl J Med"},{"key":"B95","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1651-2227.1996.tb14231.x","article-title":"Oral IgA-IgG treatment of chronic non-specific diarrhoea in infants and children","volume":"85","author":"Casswall","year":"1996","journal-title":"Acta Paediatr"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1172\/JCI107875","article-title":"Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease","volume":"54","author":"Plaut","year":"1974","journal-title":"J Clin Invest"},{"key":"B97","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1074\/jbc.M112.410811","article-title":"Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodies","volume":"288","author":"Longet","year":"2013","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"21617","DOI":"10.1074\/jbc.M114.549139","article-title":"Reconstituted human polyclonal plasma-derived secretory-like IgM and IgA maintain the barrier function of epithelial cells infected with an enteropathogen","volume":"289","author":"Longet","year":"2014","journal-title":"J Biol Chem"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fimmu.2017.01043","article-title":"Plasma-derived polyreactive secretory-like IgA and IgM opsonizing Salmonella enterica typhimurium reduces invasion and gut tissue inflammation through agglutination","volume":"8","author":"Bioley","year":"2017","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01925\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T14:19:33Z","timestamp":1693837173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01925\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":99,"alternative-id":["10.3389\/fimmu.2018.01925"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01925","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]},"article-number":"1925"}}